0 CHECKOUT

PRODUCT FILTERS

REGION

2,221
1,444
1,441
1,351
1,351

COUNTRY

1,336
147
89
87
86

CATEGORIES

  • 337
  • 323
  • 262
  • 249
  • 215
  • 197
  • 194
  • 160
  • 151
  • 147
  • 146
  • 134
  • 110
  • 104
  • 49

PRICE

318
776
1,531
4,935

PUBLISHED

248
454
2,566
4,935

PRODUCT TYPE

4,083
363
261
173
52
2
1

Oncology Drugs Market Research Reports

The American Cancer Society forecasts that 1,638,910 new cancer cases will occur in the United States in 2012. As cancer rates worldwide are increasing, the oncological sector of the pharmaceutical industry is growing fast and it will continue to provide business opportunities in the next years. However, cancer trials are some of the most complex, time consuming and expensive across all therapeutic areas. What are the new paths to success in this lucrative but challenging market?

Find out the answer in the reports, books, and subscriptions listed under Research and Markets’ Oncology category. Our top-quality publications from industry experts cover every aspect of cancer drug therapy, with a focus on: Lung Cancer, Breast Cancer, Prostate Cancer, Leukaemia, Lymphoma, Ovarian Cancer, Colon Cancer, Cervical Cancer, Brain Cancer and Bladder Cancer. So read on for the latest clinical trials, pipeline reviews, industry news, and commercial opportunities.

Key players featured in our publications include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis, Wyeth, and many more. Show Less
Read more

Sunitinib Malate Market Forecast for Pancreatic Cancer, 2016-2017, G7 Countries, (U.S., Germany, France, U.K., Italy, Spain, Japan

The sunitinib malate market for pancreatic cancer is projected to reach USD 76.7 million by 2021, at a CAGR of 13.9% from 2016 to 2021. The growing incidence of pancreatic cancer (especially pNET) and...

Published:  May 2016
Price:  From

Prostate Cancer Therapeutics - Global Strategic Business Report

The report provides separate comprehensive analytics for the US, Canada, Europe, and Rest of World. Annual estimates and forecasts are provided for the period 2015 through 2022. Also, a six-year historic...

Published:  May 2016
Price:  From

Global Oncology Ablation Market Outlook: 2015-2020 (2nd Edition)

Oncology Ablation is the minimal invasive treatment that is used to destroy or inactive the cancer cells and tumors. The market for oncology ablation is on the rise due to increasing number of cancer...

Published:  March 2016
Price:  From

Immuno-Oncology Deal Trends, 2011-15

Immuno-oncology is an emerging field in medicine that has the potential to radically change how cancer is treated. The Big Pharma and Mid Pharma peer sets are an integral part of development and have...

Published:  March 2016
Price:  From

Global Infection Control in Cancer Therapy Market Analysis & Trends - Industry Forecast to 2025

This industry report analyzes the global markets for Infection Control in Cancer Therapy across all the given segments on global as well as regional levels presented in the research scope. The study...

Published:  June 2016
Price:  From

Malignant Melanoma Pricing and Reimbursement

With several new high cost melanoma drugs available, payer decisions on whether patients can access those drugs and under what conditions are becoming more important than ever. This report covers both...

Published:  September 2015
Price:  From

Global Malignant Melanoma Drug Market & Clinical Pipeline Insight

Investigators are trying to develop innovative therapeutics for the treatment of malignant melanoma with high safety and efficacy. Surgery has remained the corner stone of cancer treatment including...

Published:  May 2016
Price:  From

Ablation Technologies Market by Product (Radiofrequency, Ultrasound, Irreversible Electroporation, Cryotherapy, Microwave) & Application - Global Forecasts to 2020

The global ablation technologies market is estimated to grow at a CAGR of 10.5% from 2015 to 2020 and will be valued at USD 4.44 billion. Although mature markets (such as the U.S., Germany, France,...

Published:  February 2016
Price:  From

Personalized Medicines In Oncology -By Tumor (Genomics, Proteomics, Metabolomics); By End User (Hospitals, Research Centers, Governmental institutions) By Technology; By Occurrence & By Geography - Forecast (2016 - 2021)

A Personalized medicine application has the largest network, mainly due to high demand for the effective cancer treatment. Apart from the huge potential of the market in personalized medicine and diagnostic...

Published:  March 2016
Price:  From

Immunotherapy Drugs Market by Type of Drug, Epidemiology, Regulatory and Pipeline Analysis - Global Forecast to 2020

In this report, the immunotherapy market is segmented into types of drugs and region. By types of drug, the market is further subsegmented into antibodies, interferons, interleukins, vaccines and checkpoint...

Published:  December 2015
Price:  From

Global Cancer Stem Cell Therapy Market Outlook 2020

Investigators discovered stem cells during their quest to find innovative cell therapy methods which could offer edge over prevailing modalities. These cells have ability to divide several times without...

Published:  April 2016
Price:  From

Global Head & Neck Cancer Market Analysis - Forecast (2014-2020)

This analysis is one of the most accurate studies performed using the combinational analytical tools. The report contains up to date financial data derived from varied research sources to present unique...

Published:  November 2015
Price:  From

HPAPIs and Cytotoxic Drugs Manufacturing Market (2nd Edition), 2016 - 2026

The ‘HPAPIs and Cytotoxic Drugs Manufacturing Market, 2016-2026 (2nd edition)’ report provides an extensive study of the rapidly growing manufacturing market of HPAPIs and cytotoxic drugs. Due to their...

Published:  March 2016
Price:  From

Global Bispecific Antibody Market & Clinical Pipeline Insight 2020

With revolutionization in the medicinal sector and more of inclination towards personalized therapy, the medical world is also witnessing the emergence of advanced analogues of monoclonal antibodies...

Published:  July 2016
Price:  From

Global Cancer Immunotoxins Market & Clinical Pipeline Insight 2020

Immunotoxins are new generation chemotherapeutic agents innovated to include the specificity of monoclonal antibody and cytotoxicity of toxins extracted from plant or bacterial source. The targeting...

Published:  July 2016
Price:  From

Antibody Drug Conjugates Market (3rd Edition)

The “Antibody Drug Conjugates Market (3rd edition), 2015-2025” report provides a comprehensive analysis of the current market landscape and future outlook of the growing pipeline of ADCs. The ADC market...

Published:  December 2015
Price:  From

Cancer CD Antigens Inhibitors Therapy Market & Pipeline Insight 2015

Pharmaceutical companies are continuously looking for better therapeutic options to effectively cure and prevent various malignancies. Several options for cancer treatment are available belonging to...

Published:  August 2015
Price:  From

T-cell Immunotherapy: Clinical Trial Tracker

After years of research tracing back to the 18th century, a gamut of novel therapies namely, CAR-T, TCR and TIL therapies, have finally reached a point of maturity. These promising therapeutic strategies,...

Published:  July 2016
Price:  From

Global Cancer Immunotherapies Market 2016-2020

About Cancer Immunotherapies Cancer immunotherapy works by enhancing the innate powers of the immune system. This has better chances of successfully fighting cancer for a long period. Also, immunotherapies...

Published:  April 2016
Price:  From

Global Chronic Lymphocytic Leukemia market 2016-2020

About the Chronic Lymphocytic Leukemia (CLL) Therapeutics Market Cancer that starts from the hematopoietic stem cells of the bone-marrow is referred to as leukemia. Leukemia can be chronic or acute...

Published:  June 2016
Price:  From
Loading Indicator

Our Clients